Pant et al. used endometrial adenocarcinoma Ishikawa cells to establish subcutaneous xenografts in nude mice and showed that inhibition of the AKT pathway in combination with progestin decreases cancer cell proliferation, increases apoptosis, and inhibits tumor growth. Here, AKT1 is linked to endometrium adenocarcinoma.